Would loss to follow-up bias the outcome evaluation of patients operated for degenerative disorders of the lumbar spine?
A study of responding and non-responding cohort participants from a clinical spine surgery registry

February 2011, Vol. 82, No. 1 , Pages 56-63 (doi:10.3109/17453674.2010.548024)
1Department of Neurosurgery, University Hospital of Northern Norway, Tromsø
2Norwegian Registry for Spine Surgery (NORspine), Northern Norway Regional Health Authority, Tromsø
3National Centre for Spinal Disorders and Department of Neurosurgery, University Hospital of St. Olav, Trondheim
4Institute of Clinical Medicine, University of Tromsø, Norway
Correspondence:



Background and purpose Loss to follow-up may bias the outcome assessments of clinical registries. In this study, we wanted to determine whether outcomes were different in responding and non-responding patients who were included in a clinical spine surgery registry, at two years of follow-up. In addition, we wanted to identify risk factors for failure to respond.

Methods 633 patients who were operated for degenerative disorders of the lumbar spine were followed for 2 years using a local clinical spine registry. Those who did not attend the clinic and those who did not answer a postal questionnaire—for whom 2 years of outcome data were missing—and who would be lost to follow-up according to the standard procedures of the registry protocols, were defined as non-respondents. They were traced and interviewed by telephone. Outcome measures were: improvement in health-related quality of life (EQ-5D), leg pain, and back pain; and also general state of health, employment status, and perceived benefits of the operation.

Results We found no statistically significant differences in outcome between respondents (78% of the patients) and non-respondents (22%). Receipt of postal questionnaires (not being summoned for a follow-up visit) was the strongest risk factor for failure to respond. Forgetfulness appeared to be an important cause. Older patients and those who had complications were more likely to respond.

Interpretation A loss to follow-up of 22% would not bias conclusions about overall treatment effects and, importantly, there were no indications of worse outcomes in non-respondents.